PRKAA2 and cardiac hypertrophy: Inasmuch as we also recently reported that AMPKα2 binds preferentially to AMPKβ1 in cardiomyocytes26, this makes AMPKα2/β1 pivotal target to reduce cardiac hypertrophy.